Batu Biologics, Inc. logo

Batu Biologics, Inc.

Immuno-oncology firm Batu Biologics is developing universal donor therapies targeting multiple pathways to enhance efficacy & specificity of cancer treatments Batu Biologics is a privately held immunotherapeutic company with laboratories at Janssen Research and Development in San Diego, is developing novel cell and gene therapies for the treatment of cancer.

In 2014, Batu Biologics license exclusive rights to 10 peptide drugs developed at UC San Diego, that have been proven to stimulate cancer-killing immune responses. Batu plans to use the licensed technology to enhance the potency of the antigen-specific immune response induced by the companys lung cancer vaccine, ValloVax.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.batubiologics.com
Founded2013
Disease Focus
Development Stage
STOCK CODENon Listed
Address
9255 Towne Centre DriveSuite 450,CA,92121
San Diego
United States
Email
Contact Number
+1 858-597-7090

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/batu-biologics-inc.” connections=”true” suffix=””]

In Dec 2017, Batu successful completed equity crowdfunding offering bringing in $1.3 Mn in capital to the Company. Batu raised nearly $7 Mn in funding since the companys inception to fund the development of its lead clinical candidate, ValloVax.